Funding text :
This work was supported by Fonds National de la Recherche Scientifique
(FRS-FNRS, FRSM 3.4516.11, MEMODYN 30446199, Belgium),
the Wallonia-Brussels Federation (grant for Concerted Research Actions
– SLEEPDEM), University of Liege, Fondation Simone et Pierre Clerdent,
European Regional Development Fund (ERDF, Radiomed Project). J.N.
was supported by University of Li`ege. M.V.E., C.S., C.B., G.V., F.C. were
supported by the FNRS-Belgium. [18F]Flutemetamol doses were provided
and cost covered by GE Healthcare Ltd (Little Chalfont, UK) as part
of an investigator sponsored study (ISS290) agreement. This agreement
had no influence on the protocol and results of the study reported here.
None of funding sources had an involvement in study design; in the
collection, analysis, interpretation of data; in the writing of the report; in
the decision to submit the article for publication.
Scopus citations®
without self-citations
11